secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aurinia Pharmaceuticals Inc. (AUPH)
CIK:        0001600620
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001600620-24-000087
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aurinia shareholders reject say-on-pay, equity plan; four directors face conditional resignations
--------------------------------------------------------------------------------

- CEO Peter Greenleaf and three other directors received less than majority support; conditional resignations submitted under Majority Voting Policy.
- Say-on-pay vote failed: 30.8M for, 45.3M against, 0.5M abstain.
- Equity Incentive Plan amendment not approved: 35.7M for, 40.5M against.
- PricewaterhouseCoopers ratified as auditor with 85.6M for, 8.1M against.
- Board will decide on the four directors' resignations within 90 days per policy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1600620/000160062024000087/0001600620-24-000087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1600620/000160062024000087/auph-20240614.htm
  HTML page:      https://secwatch.observer/filing/0001600620-24-000087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer